MOUSE MODEL FOR RETROVIRUS INDUCTION OF IMMUNODEFICIENCY
MOUSE MODEL FOR RETROVIRUS INDUCTION OF IMMUNODEFICIENCY
批准号:
3546629
负责人:
DONALD E MOSIER
金额:
$25.04万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 1989-03-31
关键词:
AIDS AIDS therapy B lymphocyte Betaherpesvirinae Candida albicans Salmonella Salmonella infections T lymphocyte acquired immunodeficiency antibody formation athymic mouse autoantibody autoimmune disorder biological models cellular immunity cellular pathology cyclosporines enzyme linked immunosorbent assay flow cytometry herpes simplex virus 1 humoral immunity immunofluorescence technique immunosuppression leukocyte activation /transformation lymphokines macrophage medical complication model design /development monoclonal antibody murine leukemia virus opportunistic infections radioimmunoassay tissue /cell culture virus cytopathogenic effect virus diseases virus infection mechanism virus virus interaction viruslike particle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objectives of our proposed studies are to understand how a model
retrovirus infection of mice leads to profound immunodeficiency disease, to
evlauate the interaction of other infectious agents with the retrovirus in
the induction of immunodeficiency, and to document that his murine disease
is an accurate and useful model for acquired immunodeficiency syndrome
(AIDS). The retrovirus that causes murine AIDS is a mixture of ecotropic
and mink cell focus-forming murine leukemia viruses termed LP-BM 5 MuLV.
Infection of susceptible strains of mice with LP-BM 5 MuLV leads to the
rapid and reproducible loss of both cellular and humoral immunity. Athymic
nude mice are resistant to most effects of LP-BM 5 MuLV infection. Our
specific aims are to determine the role of T lymphocytes in disease
induction, to examine the causes of the polyclonal B cell activation that
is a prominent feature of the disease, to study altered macrophage function
during LP-BM 5 MuLV infection, to investigate overproduction of lymphokines
during the disease, and to seek evidence of autoimmune phenomena
contributing to the rapid loss of immune function. In addition, we will
investigate the interaction of LP-BM 5 MuLV infection and several
opportunistic infections common in AIDS patients. These experimental
infectious agents include herpes simplex I, murine cytomegalovirus, Candida
albicans, and Salmonella dublin. These studies will examine both increased
susceptibility to these opportunistic pathogens following LP-BM 5 MuLV
infection and acceleration of murine AIDS by co-infection with one or more
of these agents and LP-BM 5 MuLV. Therapeutic intervention in ongoing
murine AIDs with cyclosporin A will be investigated in an attempt to
develop a strategy for treating AIDS patients.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Does preferential Th subset activation contribute to the murine acquired immunodeficiency disease (MAIDS)?
Th 亚群优先激活是否会导致小鼠获得性免疫缺陷病 (MAIDS)?
DOI:
10.1016/s0923-2494(05)80057-4
发表时间:
1994
期刊:
Research in immunology
影响因子:
--
作者:
[Torbett,BE, Mosier,DE]
通讯作者:
Mosier,DE
Inhibitory activity of interleukin B on the suppressor T cell hybrid T2D4.
白介素 B 对抑制性 T 细胞杂交体 T2D4 的抑制活性。
DOI:
--
发表时间:
1987
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[delGuercio,P, delGuercio,MF, Fridman,WH, Katz,DH]
通讯作者:
Katz,DH
Novel Mechanisms for Coreceptor Switching
-
批准号:8602642
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2013
-
负责人:DONALD E MOSIER
-
依托单位:
Novel Mechanisms for Coreceptor Switching
-
批准号:8707961
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2013
-
负责人:DONALD E MOSIER
-
依托单位:
Modeling HIV-1 primary transmission in vitro and in vivo
-
批准号:8434156
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2011
-
负责人:DONALD E MOSIER
-
依托单位:
Modeling HIV-1 primary transmission in vitro and in vivo
-
批准号:8238279
-
项目类别:
-
资助金额:$49.54万
-
财政年份:2011
-
负责人:DONALD E MOSIER
-
依托单位:
Modeling HIV-1 primary transmission in vitro and in vivo
-
批准号:8627538
-
项目类别:
-
资助金额:$74.2万
-
财政年份:2011
-
负责人:DONALD E MOSIER
-
依托单位:
Modeling HIV-1 primary transmission in vitro and in vivo
-
批准号:8113111
-
项目类别:
-
资助金额:$50.04万
-
财政年份:2011
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:7902978
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2009
-
负责人:DONALD E MOSIER
-
依托单位:
Cross-reactive HERV immunity to combat HIV-1 infection
-
批准号:7914339
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:DONALD E MOSIER
-
依托单位:
Cross-reactive HERV immunity to combat HIV-1 infection
-
批准号:7737332
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:DONALD E MOSIER
-
依托单位:
Improved Humanized Mouse Models for Vaccine Development
-
批准号:7689165
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2008
-
负责人:DONALD E MOSIER
-
依托单位:
Defining Inhibitory Mechanisms of Novel CCRS-targeted Microbicide Candidates
-
批准号:7418076
-
项目类别:
-
资助金额:$53.24万
-
财政年份:2008
-
负责人:DONALD E MOSIER
-
依托单位:
Improved Humanized Mouse Models for Vaccine Development
-
批准号:7458554
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2008
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:7866665
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:8292303
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
Recombinant CCR5 Inhibitors for Topical Microbicides
-
批准号:7174060
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:7420989
-
项目类别:
-
资助金额:$45.13万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:7624263
-
项目类别:
-
资助金额:$45.13万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:7166904
-
项目类别:
-
资助金额:$46.48万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
Recombinant CCR5 Inhibitors for Topical Microbicides
-
批准号:7286841
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
HIV Coreceptor Switching
-
批准号:7233620
-
项目类别:
-
资助金额:$45.13万
-
财政年份:2006
-
负责人:DONALD E MOSIER
-
依托单位:
海外基金